Department of Rehabilitation Sciences, The Hong Kong Polytechnic University, Hong Kong SAR, China.
JC School of Public Health and Primary Care, The Chinese University of Hong Kong, Hong Kong SAR, China.
Disabil Rehabil. 2022 Dec;44(24):7508-7515. doi: 10.1080/09638288.2021.1985631. Epub 2021 Oct 8.
To evaluate the psychometric properties of the Chinese Fear of Cancer Recurrence Inventory (FCRI-C) in follicular lymphoma (FL) survivors.
A nationwide cross-sectional study was conducted online between July and September 2020. The following psychometric properties of the FCRI-C were evaluated: construct, convergent, and discriminant validity, and reliability. Item variance was assessed using differential item functioning (DIF). A short version of the FCRI-C was developed using a two-parameter item response theory (IRT) model. The patterns of response scale, item fit, and item information were assessed. The receiver operating characteristic (ROC) curve was used to determine the clinical cut-off point for the FCRI-C.
A total of 326 FL survivors completed the questionnaire. The confirmatory factor analysis supported the bi-factor structure of the FCRI-C. The IRT analysis confirmed a 10-item short version of the FCRI-C. Satisfactory convergent and discriminant validity were underpinned by hypotheses. Cronbach's alpha of 0.95 and intraclass correlation coefficient of 0.82 indicated good internal consistency and test-retest reliability. The ROC curve determined a cut-off point of 83 and 20 for the full and short versions, respectively.
The FCRI-C used to measure and screen the levels of FCR in Chinese FL survivors was found to be valid and reliable.Implications for RehabilitationThe Chinese Fear of Cancer Recurrence Inventory (FCRI-C) is a reliable and valid measure to evaluate the fear of cancer recurrence (FCR) in follicular lymphoma survivors.The short version of the FCRI-C provides a rapid screening tool for the clinical detection of FCR in patients.The cut-off point of the FCRI-C could differentiate patients between "high" and "low" levels of FCR in clinical practice.
评估滤泡性淋巴瘤（FL）幸存者恐惧癌症复发量表中文版（FCRI-C）的心理测量特性。
2020 年 7 月至 9 月进行了一项全国性的横断面在线研究。评估了 FCRI-C 的以下心理测量特性：结构、聚合和判别有效性以及可靠性。使用差异项目功能（DIF）评估项目方差。使用双参数项目反应理论（IRT）模型开发了 FCRI-C 的简短版本。评估了响应量表模式、项目拟合和项目信息。使用接收器操作特性（ROC）曲线确定 FCRI-C 的临床截止值。
共有 326 名 FL 幸存者完成了问卷。验证性因子分析支持 FCRI-C 的双因素结构。IRT 分析证实了 FCRI-C 的 10 项简短版本。假设为假设提供了良好的聚合和判别有效性。0.95 的克朗巴赫α和 0.82 的组内相关系数表明具有良好的内部一致性和重测信度。ROC 曲线确定了完整和简短版本的 83 和 20 个截止点。
用于测量和筛查中文 FL 幸存者 FCR 水平的 FCRI-C 被发现是有效且可靠的。
恐惧癌症复发量表中文版（FCRI-C）是评估滤泡性淋巴瘤幸存者恐惧癌症复发（FCR）的可靠有效工具。
FCRI-C 的简短版本为临床检测患者 FCR 提供了快速筛查工具。
FCRI-C 的截止值可在临床实践中区分患者的“高”和“低”FCR 水平。
